CYCLERION THERAPEUTICS INC (CYCN) Stock Cash Flow
NASDAQ:CYCN - Nasdaq - US23255M2044 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -5.26M | -44.08M | -51.65M | -77.80M | -123.01M | |||
| Depreciation Amortization | 0.00 | 70.00K | 470.00K | 2.30M | 2.70M | |||
| Change In Working Capital | -4.60M | -2.85M | 1.41M | -7.59M | -2.29M | |||
| Other non cash items | -11.38M | 6.25M | 13.25M | 10.61M | 20.38M | |||
| OPERATING CASH FLOW | -21.25M | -40.61M | -36.52M | -72.49M | -102.22M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -10.00K | -1.52M | -6.89M | |||
| Other Investing Activity | 10.40M | 0.00 | 1.46M | 1.54M | 170.00K | |||
| INVESTING CASH FLOW | 10.40M | 0.00 | 1.46M | 20.00K | -6.72M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | 3.51M | N/A | |||
| Stock Issued/Repurchased | 5.02M | 30.00K | 30.79M | 24.58M | 175.51M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | 36.06M | |||
| FINANCING CASH FLOW | 5.02M | 30.00K | 30.79M | 28.09M | 211.57M | |||
| Exchange Rate Effect | 8.00K | 0.00 | 0.00 | -10.00K | -20.00K | |||
| CHANGE IN CASH | -5.81M | -40.58M | -4.27M | -44.39M | 102.61M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -21.25M | -40.61M | -36.52M | -72.49M | -102.22M | |||
| Capital Expenditure | N/A | 0.00 | -10.00K | -1.52M | -6.89M | |||
| FREE CASH FLOW | -21.25M | -40.61M | -36.53M | -74.01M | -109.11M | |||
All data in USD